DelveInsight’s “Pacemakers – Pipeline Insight and Competitive Landscape, 2021” study offers detailed insights into the Pacemakers pipeline landscape, including 20+ companies and 25+ pipeline products. Because of the rising prevalence of cardiovascular disorders around the world, the pacemaker market is expected to expand significantly in the coming years.
Some of the Key Highlights from the Pacemakers Pipeline Report.
- Micra AV, a pacemaker with atrioventricular (AV) synchrony, was approved by the Food and Drug Administration (FDA) in January 2020.
- In the Leadless II Clinical Study for Heart Arrhythmia, the first patient in the United States was implanted with the Abbott AveirTM Leadless Pacemaker on March 23, 2021.
- Atacor Ev Temporary Pacing System (Atacor), Aveir™ Leadless Pacemaker (Abbott), TPG (external temporary pacemaker) NMPA (MicroPort CRM), Boston Scientific, Leonhardt Ventures others are some pipeline devices in the Pacemaker market.
Request sample @ Pacemakers Pipeline Insights
A Pacemaker is a small device used to monitor arrhythmia that is implanted near the chest or abdomen. Arrhythmia occurs when the heart beats too quickly or too slowly, resulting in an irregular heart rhythm. Pacemakers can be used to send electrical signals to the heart to keep it in a regular rhythm and rate. Pacemakers are also used to help the heart’s chambers beat in time so that the heart can effectively pump blood to the rest of the body.
Mechanism of Pacemakers
Pacemakers monitor the rate and rhythm of an individual’s heartbeat by using low-energy electrical pulses. Traditional pacemakers use cables, also known as leads, to deliver electrical pulses. Wireless pacemakers are a newer type of pacemaker that can transmit signals without the use of leads.
Gain more knowledge about pacemakers @ Pacemakers Market Outlook
Pacemakers Key Companies
- MicroPort CRM
- Boston Scientific
- Leonhardt Ventures
By Product type
By Stage Type
Pacemakers Market Drivers
- Increasing number of cardiac arrhythmia
- Increasing technological advancement
- Increasing levels of geriatric population
Pacemakers Market Barriers
- Strict regulatory requirements for approval of products
- Risk of oversensing and under-sensing
Pacemakers Unmet Needs
- Implant rejections in patients is a major unmet need
- Side-effects associated with Pacemaker devices
Reach out for more information @ Pacemakers Assessment and Market Dynamics
Scope of the Report
Pacemakers Key Companies: Atacor, Abbott, MicroPort CRM, Boston Scientific, Leonhardt Ventures, among others
Table of Contents
|3.||Pacemakers: Background and Overview|
|4.||Listing of Marketed Pacemakers: Company Profiles|
|5.||Listing of Pipeline Pacemakers: Company Profiles|
|6.||Pacemakers: Competitive Assessment of Listed Pipeline Products|
|7.||Pacemakers: Competitive Benchmarking: By Company|
|8.||Pacemakers – Commercialisation Activity|
|9.||Pacemakers: Regulatory Overview|
|10.||Pacemakers: Reimbursement Overview|
|11.||Pacemakers: Market Dynamics|
|13.||Conclusion & Future Growth Perspectives|
Know more what’s covered in the Pacemakers Pipeline Assessment Report
Biopsy Devices Pipeline Insights
Get comprehensive analysis of Biopsy Devices pipeline devices and key companies including 3DBiopsy Inc, Actuated Medical Inc, Arch Medical Devices Ltd, Boston Scientific Corp, C. R. Bard Inc, MI4 Spine, LLC, among others.
Coronary Stents Pipeline Insights
Get comprehensive analysis of Coronary Stents pipeline devices and key companies including REVA Medical Inc, Rontis AG, Stentys SA, Tepha Inc, among others.
Vascular Grafts Pipeline Insights
Get comprehensive analysis of Vascular Grafts pipeline devices and key companies including RegenaGraft, Humacyte Inc, Peca Labs Inc, among others.
Hemodialysis Catheters Pipeline Insights
DelveInsight’s, “Hemodialysis Catheters – Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 15+ companies and 15+ pipeline devices in Hemodialysis Catheters pipeline landscape.
Deep Brain Stimulation Devices Pipeline Insights
DelveInsight’s, “Deep Brain Stimulation Devices – Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in deep brain stimulation (DBS) devices pipeline landscape.
Urinary Catheters Pipeline Insights
DelveInsight’s, “Urinary Catheters–Pipeline Insight and Competitive Landscape 2020,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Urinary Catheters pipeline landscape.
Liquid Biopsy for Cancer Diagnostics Pipeline Insights
Get comprehensive analysis of Liquid Biopsy for Cancer Diagnostics pipeline devices and key companies including Roche, Qiagen, Helio Health, Bio-Techne, ArcherDX, among others.
Colonoscopes Pipeline Insights
DelveInsight’s, “Colonoscopes – Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Colonoscopes pipeline landscape.
Electroencephelographs Pipeline Insights
DelveInsight’s, “Electroencephelographs (EEG) – Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape.
Get comprehensive analysis of Artificial Lung Devices pipeline devices and key companies including Miromatrix, Getinge, Xenios AG, Abiomed, Medtronic, XVIVO Perfusion, Charles Stark Draper Laboratory Inc, among others.
For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Sandeep Joshi www.delveinsight.com